DHFR2
Dihydrofolate reductase 2, mitochondrial
Also known as: DHFRL1, DHFRP4, DYR2_HUMAN, FLJ16119
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86XF0
- Gene
- DHFR2
- Ensembl
- ENSG00000178700
- Chromosome
- 3
- Canonical length
- 187 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Enables dihydrofolate reductase activity and mRNA binding activity. Involved in tetrahydrofolate metabolic process and thymidine biosynthetic process. Located in mitochondrial inner membrane and mitochondrial matrix. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
187 residues, UniProt reviewed canonical sequence.
>Q86XF0|DHFR2
1 MFLLLNCIVA VSQNMGIGKN GDLPRPPLRN EFRYFQRMTT TSSVEGKQNL VIMGRKTWFS
61 IPEKNRPLKD RINLVLSREL KEPPQGAHFL ARSLDDALKL TERPELANKV DMIWIVGGSS
121 VYKEAMNHLG HLKLFVTRIM QDFESDTFFS EIDLEKYKLL PEYPGVLSDV QEGKHIKYKF
181 EVCEKDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DHFR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 8 nTPM
Expression across tissuesHPA
Tissue
- ovary: 8 nTPM
- endometrium: 7.3 nTPM
- liver: 6.2 nTPM
- thyroid gland: 6.2 nTPM
- parathyroid gland: 6.1 nTPM
- cerebral cortex: 6 nTPM
Single-cell type
- epicardial cells: 46 nCPM
- cardiomyocytes: 43 nCPM
- late primary spermatocytes: 41 nCPM
- tuft cells: 35 nCPM
- early spermatids: 28 nCPM
- epididymal principal cells: 28 nCPM
Immune cell
- MAIT T-cell: 3.3 nTPM
- naive CD4 T-cell: 3.3 nTPM
- T-reg: 3.2 nTPM
- naive CD8 T-cell: 3 nTPM
- memory CD8 T-cell: 2.9 nTPM
- memory CD4 T-cell: 2.4 nTPM
Brain region
- white matter: 16 nTPM
- cerebellum: 15 nTPM
- basal ganglia: 14 nTPM
- cerebral cortex: 14 nTPM
- pons: 14 nTPM
- choroid plexus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.44
- gnomAD pLI
- 0.22
- DepMap mean gene effect
- -0.46
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- dihydrofolate metabolic process
- folic acid metabolic process
- one-carbon metabolic process
- tetrahydrofolate biosynthetic process
- tetrahydrofolate metabolic process
- thymidine biosynthetic process
Molecular functions
- dihydrofolate reductase activity
- mRNA binding
- NADP binding
- folate reductase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DHFR2 as an antibody target. Whether an autoantibody or antibody against DHFR2 could matter depends on whether native DHFR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DHFR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DHFR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...